Salem Investment Counselors’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$37.4K Hold
200
– – ﹤0.01% 672
2026
Q1
$37.7K Buy
+200
New +$42.1K ﹤0.01% 653
2025
Q4
– Sell
-200
Closed -$40.6K – 1065
2025
Q3
$40.6K Hold
200
– – ﹤0.01% 632
2025
Q2
$35.2K Hold
200
– – ﹤0.01% 643
2025
Q1
$26.9K Hold
200
– – ﹤0.01% 670
2024
Q4
$25.2K Hold
200
– – ﹤0.01% 691
2024
Q3
$33.2K Hold
200
– – ﹤0.01% 663
2024
Q2
$26.6K Hold
200
– – ﹤0.01% 681
2024
Q1
$21K Hold
200
– – ﹤0.01% 701
2023
Q4
$15.1K Hold
200
– – ﹤0.01% 741
2023
Q3
$13.2K Hold
200
– – ﹤0.01% 747
2023
Q2
$16.3K Hold
200
– – ﹤0.01% 738
2023
Q1
$11.9K Hold
200
– – ﹤0.01% 784
2022
Q4
$9.76K Hold
200
– – ﹤0.01% 785
2022
Q3
$10K Hold
200
– – ﹤0.01% 762
2022
Q2
$11K Hold
200
– – ﹤0.01% 769
2022
Q1
$17K Hold
200
– – ﹤0.01% 672
2021
Q4
$16K Buy
+200
New +$14.6K ﹤0.01% 750

Other funds holding THC

Salem Investment Counselors's THC Position: Q2 2026 in Review

Salem Investment Counselors held its Tenet Healthcare (THC) position steady in Q2 2026 at 200 shares worth $37.4K. The position accounts for ﹤0.01% of the portfolio, ranked #672.

Salem Investment Counselors first reported a position in THC in Q4 2021 and has held it in 18 quarters since. The position peaked at $40.6K in Q3 2025. 681 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Salem Investment Counselors held 200 shares of Tenet Healthcare worth $37.4K as of Q2 2026.
  • Salem Investment Counselors left its Tenet Healthcare share count unchanged in Q2 2026.
  • Tenet Healthcare made up ﹤0.01% of Salem Investment Counselors's portfolio in Q2 2026, its #672 holding.
  • Salem Investment Counselors first reported a position in Tenet Healthcare in Q4 2021 and has held it in 18 quarters since.
  • Salem Investment Counselors's Tenet Healthcare position peaked at $40.6K in Q3 2025.
  • 681 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Salem Investment Counselors's 13F filing for Q2 2026, filed 14 Jul 2026.